SCHEMBL19903515

SCHEMBL19903515

CC(C)(C)c1ccc2c(c1)c1ccccc1n2-c1cc(C#N)c(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1-n1c2ccccc2c2cc(C(C)(C)C)ccc21

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.36
AR P10275 5/20 0.35
RORC P51449 2/20 0.34
PPARG P37231 1/20 0.33
PPARA Q07869 1/20 0.33
RAPGEF3 O95398 1/20 0.33
RAPGEF4 Q8WZA2 1/20 0.33
SLC22A12 Q96S37 3/20 0.32
GPBAR1 Q8TDU6 1/20 0.32
TSHR P16473 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
PGR P06401 2/20 0.32
NR1H3 Q13133 1/20 0.32
RORA P35398 1/20 0.31
RORB Q92753 1/20 0.31
HRH1 P35367 1/20 0.31
HTR6 P50406 1/20 0.31
IMPDH2 P12268 1/20 0.31
XDH P47989 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20617049 0.95 KIF11 (0.34) KIF11ARRORCPPARGPPARA
SCHEMBL19903532 0.95 KIF11 (0.41) KIF11ARRORCPPARGPPARA
SCHEMBL19903505 0.95 KIF11 (0.39) KIF11ARRORCGPBAR1TSHR
SCHEMBL19903491 0.94 RAPGEF3 (0.35) KIF11ARPPARGRAPGEF3RAPGEF4
SCHEMBL19912570 0.94 KIF11 (0.34) KIF11ARRORCPPARGPPARA
SCHEMBL19918034 0.94 KIF11 (0.36) KIF11ARRORCPPARGPPARA
SCHEMBL20617042 0.90 KIF11 (0.39) KIF11ARRORCPPARGPPARA
SCHEMBL22564562 0.89 KIF11 (0.36) KIF11ARRORCGPBAR1TSHR
SCHEMBL19903576 0.89 AR (0.34) KIF11ARRORCTSHRSMN1; SMN2
SCHEMBL22822670 0.89 RXRA (0.37) KIF11RAPGEF3RAPGEF4GPBAR1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10439151-B2 Organic molecules, especially for use in organic optoelectronic devices CYNORA GMBH (DE) 2019-10-08 US disclosed
EP-3360945-B1 ORGANIC ELECTROLUMINESCENT DEVICE CYNORA GMBH (DE) 2019-04-24 EP disclosed
EP-3287450-B1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-03-20 EP disclosed
US-20180062086-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
EP-3287450-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10439151-B2 Organic molecules, especially for use in organic optoelectronic devices OR10J3, ORC3, AOC3 KIF11 3253/4885AR 4190/4885RORC 2856/4885
US-20180062086-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, ORC3, AOC3 KIF11 3316/4885AR 4212/4885RORC 2874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.